Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

AFT Pharmaceuticals Surpasses $200M Revenue, Eyes $300M by FY2027 Despite Dip in Profits

AFT Pharmaceuticals Ltd (ASX:AFP)has outperformed its financial targets for the 2025 fiscal year, delivering$208 million in operating revenue—a 6% year-on-year increase and a significant milestone for the company. As AFT looks ahead, it has now set its sights on a more ambitious target:reaching $300 …

Team Kalkine | 22 May 2025

Mayne Pharma Shares Plunge 30% as Cosette Threatens to Exit AU$672 Million Acquisition

Shares in Mayne Pharmaceuticals (ASX:MYX) plummeted 29.78% to AU$4.55 in morning trade on Wednesday after Cosette Pharmaceuticals, its prospective acquirer, raised concerns about a possible “material adverse change” in Mayne’s financial condition, threatening to withdraw from the AU$672 million takeover deal.

Team Kalkine | 21 May 2025

ResMed (ASX: RMD) Shares Fall Amid Competitive Pressure From Emerging OSA Drug Candidate

ResMed Inc. (ASX: RMD) based in San Diego, is a global medical device company listed on the NYSE and ASX, specializing in sleep apnoea therapy and digital respiratory health solutions. The Shares of ResMed Inc. (ASX: RMD) declined 5% to A$36.90 on Tuesday after …

Team Kalkine | 20 May 2025

Amplia Shares Surge 58% After Key Milestone in Pancreatic Cancer Trial

Amplia Therapeutics (ASX:ATX) soared 58% on Thursday after announcing a major milestone in its Phase 1b/2a ACCENT clinical trial for pancreatic cancer. The trial, evaluating its FAK inhibitor narmafotinib combined with chemotherapy, has now recorded 15 confirmed partial responses (PRs).

Team Kalkine | 15 May 2025

PolyNovo Soars Over 14% on Breakthrough Diabetes Treatment Results

Shares ofPolyNovo Ltd (ASX:PNV)surged as much as14.7% on Tuesday, reachingAU$1.675, following a groundbreaking announcement regarding the company’s NovoSorb BTM (Biodegradable Temporising Matrix) technology and its application in treatingType 1 diabetes.

Team Kalkine | 13 May 2025

Orthocell Secures Hong Kong Approval for Remplir™ as Global Expansion Accelerates

Orthocell Ltd (ASX:OCC)continues to boost its global footprint with thelatest regulatory milestonefor its flagship nerve repair device,Remplir™, securing approval fromHong Kong’s Department of Health Medical Device Division. The greenlight allows Orthocell to officially commence sales in the strategically significant Hong Kong market—widely recognised as …

Team Kalkine | 13 May 2025

Healius Shares Sink 30% After Going Ex-Dividend Despite Positive News

Healius Ltd (ASX:HLS) shares are experiencing a sharp sell-off today, plunging 30% to a 52-week low of $1.07 in morning trade, as the stock goes ex-dividend for a special payout.

Team Kalkine | 09 May 2025

Pro Medicus Secures AU$20M Deal with University of Iowa Health Care for Cloud Imaging Platform

Pro Medicus Limited [ASX:PME] has announced a landmark A$20 million, five-year contract with University of Iowa Health Care (UI Health Care), marking a significant expansion of its presence in the U.S. healthcare technology market. The agreement will see the full deployment of the Visage …

Team Kalkine | 08 May 2025

MedAdvisor Receives Takeover Proposal for ANZ Division From Global Software Giant

MedAdvisor Limited (ASX:MDR)has confirmed it has received anon-binding Letter of Intent (LOI)from a major multinational listed software company to acquire its Australia and New Zealand (ANZ) business division. The offer—still confidential in detail—includes acash considerationthat the MedAdvisor board believes represents asignificant premiumover its current …

Team Kalkine | 07 May 2025

Healius Jumps on $300M Special Dividend Post Lumus Imaging Sale

Healius Ltd (ASX:HLS) shares surged on Monday, defying broader market weakness after the company unveiled plans to reward shareholders with a substantial special dividend. The move comes in the wake of the successful divestment of its Lumus Imaging business, unlocking significant capital for the …

Team Kalkine | 06 May 2025
Support

Hi! How can we help you today?

Loading…